Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.33 |
| ▸ | JAK2 | O60674 | 1/20 | 0.32 |
| ▸ | JAK1 | P23458 | 1/20 | 0.32 |
| ▸ | TYK2 | P29597 | 1/20 | 0.32 |
| ▸ | JAK3 | P52333 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17106333 | 1.00 | LMNA (0.33) | LMNAALDH1A1HSD17B10NLRP3JAK2 | |
| SCHEMBL17106335 | 1.00 | LMNA (0.33) | LMNAALDH1A1HSD17B10NLRP3JAK2 | |
| SCHEMBL6256094 | 0.81 | — | — | |
| SCHEMBL17029138 | 0.81 | ALDH1A1 (0.43) | LMNAALDH1A1HSD17B10NLRP3JAK2 | |
| SCHEMBL5696892 | 0.81 | ALDH1A1 (0.43) | LMNAALDH1A1HSD17B10NLRP3JAK2 | |
| Hydrochloric Acid SCHEMBL28064641 | 0.79 | — | — | |
| SCHEMBL26077565 | 0.79 | NR1H2 (0.30) | — | |
| SCHEMBL21243354 | 0.79 | TP53 (0.49) | LMNA | |
| SCHEMBL21243357 | 0.79 | MEN1 (0.38) | ALDH1A1 | |
| SCHEMBL8333230 | 0.78 | LMNA (0.34) | LMNAALDH1A1HSD17B10NLRP3JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3122847-A1 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2017-02-01 | — | — | EP | claimed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | claimed |
| WO-2015148743-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2015-10-01 | — | — | WO | claimed |
| US-20150275132-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2015-10-01 | — | — | US | claimed |
| EP-3521409-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2019-08-07 | — | — | EP | disclosed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160289593-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | LMNA 2632/4885ALDH1A1 1292/4885HSD17B10 1947/4885 |
| US-20150275132-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | LMNA 2632/4885ALDH1A1 1292/4885HSD17B10 1947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.